|
RIOK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.136200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.838200E-02 |
| Normal-vs-Stage2 |
8.459800E-01 |
| Normal-vs-Stage3 |
6.466600E-01 |
| Normal-vs-Stage4 |
7.607000E-01 |
| Stage1-vs-Stage2 |
1.871620E-01 |
| Stage1-vs-Stage3 |
7.123100E-03 |
| Stage1-vs-Stage4 |
1.479890E-02 |
| Stage2-vs-Stage3 |
5.451000E-01 |
| Stage2-vs-Stage4 |
6.471400E-01 |
| Stage3-vs-Stage4 |
8.821000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.373400E-01 |
| Normal-vs-AfricanAmerican |
6.414600E-01 |
| Normal-vs-Asian |
3.686400E-01 |
| Caucasian-vs-AfricanAmerican |
8.926800E-01 |
| Caucasian-vs-Asian |
5.990000E-01 |
| AfricanAmerican-vs-Asian |
5.937000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.461200E-01 |
| Normal-vs-Female |
5.480200E-02 |
| Male-vs-Female |
1.490180E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.197200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.565600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.324800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.804800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.207800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.999200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.526400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.762400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.656200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.497610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.630400E-02 |
| Normal-vs-Grade 2 |
8.475800E-03 |
| Normal-vs-Grade 3 |
4.390600E-01 |
| Normal-vs-Grade 4 |
2.680400E-01 |
| Grade 1-vs-Grade 2 |
8.644000E-02 |
| Grade 1-vs-Grade 3 |
3.557800E-02 |
| Grade 1-vs-Grade 4 |
2.702200E-02 |
| Grade 2-vs-Grade 3 |
3.12069999997E-06 |
| Grade 2-vs-Grade 4 |
4.155500E-04 |
| Grade 3-vs-Grade 4 |
5.224400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.898700E-03 |
| Normal-vs-ccB subtype |
3.918600E-01 |
| ccA subtype-vs-ccB subtype |
3.99499999970132E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.426000E-01 |
| Normal-vs-N1 |
4.762400E-01 |
| N0-vs-N1 |
2.963000E-01 |
|
|
